Volume 14, Issue 3 (3-2016)                   IJRM 2016, 14(3): 213-216 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghanei A, Mohammadzade G, Zarepur E, Soheilikhah S. Congenital adrenal hyperplasia and vanishing testis: rare case of male pseudohermaphroditism. IJRM 2016; 14 (3) :213-216
URL: http://ijrm.ir/article-1-729-en.html
1- Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , g.mohammadzade@gmail.com
3- Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract:   (2580 Views)
Background: Congenital adrenal hyperplasia (CAH) and vanishing testes are uncommon diseases that can result from hormonal and mechanical factors. Classic CAH is determined by ambiguous genitalia and increase in amount of 17-Hydroxyprogesterone. Simultaneous occurrence of CAH and vanishing testes is a rare condition.
Case: A 22-year-old boy, known case of CAH who was diagnosed as female pseudohermaphroditism due to ambiguous genitalia, was referred to Shahid Sadoughi Hospital, Yazd, Iran with colicky abdominal pain and hematuria. Ultrasonography has been performed and prostate tissue was reported. Karyotyping was done because of uncertainty in primary diagnosis, which revealed 46XY. For finding location of testes, ultrasonography and MRI were done and nothing was found in abdomen, inguinal canal or scrotum. Inhibin B serum level was measured to find out whether testis tissue was present in the body, which was <1 pg/ml and vanishing testis was confirmed.
Conclusion: Early diagnosis and treatment are essential to prevent further sequels and karyotyping for all patients with CAH is recommended. Lifelong treatment with synthetic glucocorticoid replacement is necessary.
Full-Text [PDF 117 kb]   (750 Downloads) |   |   Full-Text (HTML)  (707 Views)  
Type of Study: Original Article |

References
1. Phyllis W, Speiser MD, Perrin C, White MD. Congenital adrenal hyperplasia. N Engl J Med 2003; 349: 776-88. [DOI:10.1056/NEJMra021561]
2. Therrell BL. Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30: 15-30. [DOI:10.1016/S0889-8529(08)70017-3]
3. Bercovici JP, Fiet J, Gibault L, Volant A, Abalain JH, Floch HH, et al. Testicular adrenal rest tumours in salt wasting congenital adrenal hyperplasia (in vivo and in vitro studies). J Steroid Biochem Mol Biol 2005; 93: 67-70. [DOI:10.1016/j.jsbmb.2004.10.023]
4. Pirgon Ö, Dündar BN. Vanishing testes: a literature review. J Clin Res Pediatr Endocrinol 2012; 4: 116-120. [DOI:10.4274/Jcrpe.728]
5. White PC, Speiser PW. Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Endocrine Rev 2000; 21: 245-291. [DOI:10.1210/er.21.3.245]
6. Hughes IA. Congenital Adrenal Hyperplasia: A Lifelong Disorder. Horm Res 2007; 68: 84-89. [DOI:10.1159/000110585]
7. Speiser PW, White PC. Congenital Adrenal Hyperplasia. N Engl J Med 2003; 349: 776-788. [DOI:10.1056/NEJMra021561]
8. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A. New M.I. High frequency of non-classical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 37: 650-667.
9. Eugster EA, Dimeglio LA, Wright JC, Freidenberg GR, Seshadri R, Pescovitz OH. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: A meta-analysis. J Pediatr 2001; 138: 26-32. [DOI:10.1067/mpd.2001.110527]
10. Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB. Clinical review: Adult height in patients with congenital adrenal hyperplasia: A systematic review and metaanalysis. J Clin Endocrinol Metab 2010; 95: 4161-4172. [DOI:10.1210/jc.2009-2616]
11. Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB, Et al. Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J Clin Endocrinol Metab 2010; 95: 4161-4172. [DOI:10.1210/jc.2009-2616]
12. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003; 349: 776-788. [DOI:10.1056/NEJMra021561]
13. Therrell BL. Newborn screening forcongenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30: 15-30. [DOI:10.1016/S0889-8529(08)70017-3]
14. Migeon CJ, Wisniewski AB. Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency: growth, development, andtherapeutic considerations. Endocrinol Metab Clin North Am 2001; 30: 193-206. [DOI:10.1016/S0889-8529(08)70026-4]
15. Pourkeramati F, Soltanghoraee H, Amirjannati N, Akhondi MM, KhorramKhorshid HR. Prevalence of intratubular germ cell neoplasia in cryptorchid testes of infertile men. Iran J Reprod Med 2013; 11: 339-342.
16. Achermann JC, Hughes JA. Disorders of sex development. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 11th Ed. Philadelphia, Pa: Saunders Elsevier; 2008.
17. Lambert SM, Vilain EJ, Kolon TF.A practical approach to ambiguous genitalia in the newborn period. Urol Clin North Am 2010; 37: 195-205. [DOI:10.1016/j.ucl.2010.03.014]
18. Rousso I, Iliopoulos D, Athanasiadou F, Zavopoulou L, Vassiliou G, Voyiatzis N. Congenital bilateral anorchia: hormonal, molecular and imaging study of a case. Genet Mol Res 2006; 5: 638-642.
19. Fritzsche PJ, Hricak H, Kogan BA, Winkler ML, Tanagho EA. Undescended testis: value of MR imaging. Radiology 1987; 164: 169-173. [DOI:10.1148/radiology.164.1.2884693]
20. Zenaty D, Dijoud F, Morel Y, Cabrol S, Mouriquand P, Nicolino M, et al. Bilateral anorchia in infancy: occurence of micropenis and the effect of testosterone treatment. J Pediatr 2006; 149: 687-691. [DOI:10.1016/j.jpeds.2006.07.044]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb